# Gemcitabine Plus Carboplatin Versus Carboplatin Monotherapy in Patients With Advanced Ovarian Cancer

> **NCT00102414** · PHASE3 · COMPLETED · sponsor: **AGO Study Group** · enrollment: 356 (—)

## Conditions studied

- Ovarian Cancer

## Interventions

- **DRUG:** Gemcitabine

## Key facts

- **NCT ID:** NCT00102414
- **Lead sponsor:** AGO Study Group
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1999-09
- **Primary completion:** —
- **Final completion:** 2004-11
- **Target enrollment:** 356 (—)
- **Last updated:** 2006-11-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00102414

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00102414, "Gemcitabine Plus Carboplatin Versus Carboplatin Monotherapy in Patients With Advanced Ovarian Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00102414. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*